Category: Clinical Trial
Clinical Trial market research reports by Magna Intelligence
-
Global Drug Screening Databank Market Report
Global Drug Screening Databank Market Report The Drug Screening market was valued at $5,721.3 Million in 2022, and is projected to reach $17,880.4 Million by 2031 growing at a CAGR of 13.57% from 2023 to 2031. Drug Screening Service segment is expected to be the highest contributor to this market, w ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
Global Investigational Drug CDMO Databank Market Report.pdf The Varicose Veins Treatment Devices market was valued at $1,315.6 Million in 2022, and is projected to reach $2,104.4 Million by 2031 growing at a CAGR of 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contrib ... Read More
-
Global Cell And Gene Therapy Clinical Trials Databank Market Report
Global Cell And Gene Therapy Clinical Trials Databank Market Report The Cell And Gene Therapy Clinical Trials market was valued at $25,130.0 Million in 2020, and is projected to reach $43,026.4 Million by 2029 growing at a CAGR of 6.20% from 2021 to 2029. Cardiology segment is expected to be the hig ... Read More
-
Global In Silico Clinical Trials Databank Market Report
Global In Silico Clinical Trials Databank Market Report The In Silico Clinical Trials market was valued at $2,781.6 Million in 2022, and is projected to reach $4,679.1 Million by 2031 growing at a CAGR of 5.99% from 2023 to 2031. Medical Devices segment is expected to be the highest contributor to t ... Read More
-
Global Investigational Drug CDMO Databank Market Report
Global Investigational Drug CDMO Databank Market Report TThe Investigational Drug CDMO market was valued at $4,665.4 Million in 2022, and is projected to reach $7,579.6 Million by 2031 growing at a CAGR of 5.58% from 2023 to 2031. Small Molecule segment is expected to be the highest contributor to t ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report The Idiopathic Pulmonary Fibrosis Treatment market was valued at $2,614.3 Million in 2020, and is projected to reach $6,619.3 Million by 2029 growing at a CAGR of 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be ... Read More
-
Leading Clinical Trial Supplies Clinical Phase Markets Databank
Leading Clinical Trial Supplies Clinical Phase Markets Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Phase III segment is expected to be the highest contributor to ... Read More
-
Latin America, Middle East & Africa Clinical Trial Supplies Market Databank
Latin America, Middle East & Africa Clinical Trial Supplies Market Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest ... Read More
-
Leading Clinical Trial Supplies Country Markets Databank
Leading Clinical Trial Supplies Country Markets Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Europe is expected to be the highest contributor to this market, with $ ... Read More
-
North America Clinical Trial Supplies Market Databank
North America Clinical Trial Supplies Market Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this m ... Read More
-
Europe Clinical Trial Supplies Market Databank
Europe Clinical Trial Supplies Market Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, ... Read More
-
Leading Clinical Trial Supplies End Use Markets Databank
Leading Clinical Trial Supplies End Use Markets Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to th ... Read More
-
Asia-Pacific Clinical Trial Supplies Market Databank
Asia-Pacific Clinical Trial Supplies Market Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this ma ... Read More
-
Global Clinical Trial Supplies Market Databank
Global Clinical Trial Supplies Market Databank The Clinical Trial Supplies market was valued at $2,090.0 Million in 2020, and is projected to reach $3,991.9 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Pharmaceutical segment is expected to be the highest contributor to this market, ... Read More
Research Assistance
